Vascular News and Research

RSS

Avastin slows growth of gliomas

Avastin, a relatively new type of drug that shrinks cancerous tumors by cutting off their blood supply, can slow the growth of the most common and deadly form of brain cancer, a pilot study conducted at Duke University Medical Center has found.

20 Feb 2007

C-Reactive protein plays a direct role in the onset of hypertension

We have discovered that C-Reactive Protein (CRP) is not merely a marker of the risk of hypertension, it actually induces hypertension.

19 Feb 2007

Chocolate can give a short-term boost to memory

Eating chocolate could help to sharpen up the mind and give a short-term boost to cognitive skills, a University of Nottingham expert has found.

19 Feb 2007

People from lower socioeconomic backgrounds worse off following heart attack

People from lower socioeconomic backgrounds who suffer a heart attack come to the emergency department more often, are less likely to be treated aggressively and have higher mortality rates a year after the attack, says new University of Alberta research that has important implications for access to cardiac care.

13 Feb 2007

Expanded endonasal approach surgery removes tumors once deemed to be inoperable

A first-of-its-kind study published in the February issue of the Journal of Neurosurgery: Pediatrics suggests endoscopic brain surgery, pioneered by surgeons at the University of Pittsburgh Medical Center, has the potential to be safer and often more effective than conventional surgery in children with life-threatening conditions.

12 Feb 2007

FDA approves temporary limb salvage shunt

The U.S. Food and Drug Administration (FDA) has cleared for U.S. marketing a vascular shunt, a medical device that can help save the arms and legs of soldiers critically injured in combat as well as individuals in other trauma settings and emergency situations.

11 Feb 2007

Aprotinin use associated with an increased risk of death following CABG surgery

Aprotinin, a drug used for limiting blood loss in patients undergoing cardiac surgery, is associated with an increased risk of death during five years following the surgery, according to a new study in the February 7 issue of JAMA: The Journal of the American Medical Association.

7 Feb 2007

New understanding of blood pressure gene could lead to new treatments

Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer.

5 Feb 2007

Effects of acute oral antioxidants on diving-induced alterations in cardiovascular function

A new study, published in The Journal of Physiology, shows that acute oral intake of largely accepted antioxidants Vitamin C and E prior to a scuba dive can reduce alterations in cardiovascular function, particularly acute endothelial dysfunction, that are caused by a single field air dive.

4 Feb 2007

Dll4 signalling through Notchi regulates formation of tip cells during angiogenesis

All tissues, sick and healthy alike, need a blood supply to survive and grow. The key to many medical problems, like preventing tumour development, is therefore to obstruct the spread of the blood vessels. Research scientists at Karolinska Institutet have now discovered a heretofore unknown mechanism for how the body links together its blood vessels.

29 Jan 2007

Linemen more than twice as likely as other players to have metabolic syndrome

After retirement, National Football League (NFL) linemen - generally the heaviest players - are more than twice as likely as other players to have a syndrome that puts them at risk for heart disease, stroke and other cardiovascular diseases

28 Jan 2007

Surface analysis of stents

The fastest growing market for surface analysis techniques is in the development and manufacture of vascular stents.

16 Jan 2007

Neuren reports successful NNZ-2566 safety trial results

Neuren Pharmaceuticals Ltd has successfully completed a Phase 1 safety and tolerability trial of its second lead candidate, NNZ-2566, which is being developed to treat traumatic brain injury (TBI).

16 Jan 2007

Milk eliminates cardiovascular health benefits of tea

Research published on-line in European Heart Journal has found that the protective effect that tea has on the cardiovascular system is totally wiped out by adding milk.

9 Jan 2007

Milk wipes out heart benefits offered by tea

Research published online in the European Heart Journal has found that the protective effect that tea has on the cardiovascular system is totally wiped out by adding milk.

9 Jan 2007

Medicare begins to cover ultrasounds to detect aortic aneurysms

Medicare on Jan. 1 began to cover ultrasounds to detect abdominal aortic aneurysms in beneficiaries at high risk for the condition, the Charlotte Observer reports.

7 Jan 2007

High uric acid levels indicate risk for cognitive problems in old age

Researchers at the Johns Hopkins and Yale university medical schools have found that a simple blood test to measure uric acid, a measure of kidney function, might reveal a risk factor for cognitive problems in old age.

2 Jan 2007

Vascular targeted nanoparticles for imaging and treatment of brain tumors

Combining two promising approaches to diagnosing and treating cancer, a multidisciplinary research team at the University of Michigan has created a targeted multifunctional polymer nanoparticle that successfully images and kills brain tumors in laboratory animals.

4 Dec 2006

Poor memory and slow reactions linked to heart attacks

According to British research, people with a below average mental agility are prone to heart attacks.

27 Nov 2006

VNUS Medical Technologies announces favorable ruling in patent case

VNUS Medical Technologies, Inc has announced that United States District Judge Maxine M. Chesney of the United States District Court for the Northern District of California issued a Markman order in the litigation brought by VNUS Medical Technologies against Diomed Holdings, Inc. and Diomed, Inc., AngioDynamics, Inc. and Vascular Solutions, Inc. (the "defendants").

23 Nov 2006